Propanc Biopharma (PPCB) Debt Ratio (2011 - 2025)
Propanc Biopharma (PPCB) posted quarterly Debt Ratio of 0.01 for Q4 2025, down 99.87% year-over-year from 6.27 in Q4 2024, and up 33.76% quarter-over-quarter from 0.01 in Q3 2025.
Propanc Biopharma (PPCB) Debt Ratio (2011 - 2025) Analysis & Trends
Propanc Biopharma (PPCB) has reported Debt Ratio for 15 consecutive years, with 0.01 the latest figure, recorded in Q4 2025.
- In Q4 2025, Debt Ratio fell 99.87% year-over-year to 0.01; the TTM figure through Dec 2025 stood at 0.01 (down 99.87% YoY), while the FY2025 annual figure was 0.03, down 99.48% from the prior year.
- Debt Ratio improved to 0.01 in Q4 2025 per PPCB's latest filing, from 0.01 in the prior quarter.
- Across five years, Debt Ratio topped out at 33.88 in Q1 2021 and bottomed at 0.01 in Q3 2025.
- Historically, Debt Ratio has averaged 6.3 across 5 years, with a median of 4.63 in 2023.
- Annual changes were most pronounced in 2024 — Debt Ratio soared 2451.04% — and 2025, when it slumped 99.93%.
- Propanc Biopharma's Debt Ratio stood at 8.83 in 2021, then sank by 87.87% to 1.07 in 2022, then soared by 179.14% to 2.99 in 2023, then jumped by 109.71% to 6.27 in 2024, then slumped by 99.87% to 0.01 in 2025.
- Business Quant data shows PPCB's Debt Ratio at 0.01 in Q4 2025, 0.01 in Q3 2025, and 0.03 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 0.05 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 0.05 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 0.12 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 0.26 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.47 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 0.03 |
| 10 | Propanc Biopharma | 587,855.41 | 587,855.41 | - | 0.01 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.01 |
| Sep 30, 2025 | 0.01 |
| Jun 30, 2025 | 0.03 |
| Mar 31, 2025 | 0.02 |
| Dec 31, 2024 | 6.27 |
| Sep 30, 2024 | 8.28 |
| Jun 30, 2024 | 6.33 |
| Mar 31, 2024 | 16.87 |
| Dec 31, 2023 | 2.99 |
| Sep 30, 2023 | 2.36 |
| Jun 30, 2023 | 7.56 |
| Mar 31, 2023 | 0.66 |
| Dec 31, 2022 | 1.07 |
| Sep 30, 2022 | 9.69 |
| Jun 30, 2022 | 11.72 |
| Mar 31, 2022 | 6.35 |
| Dec 31, 2021 | 8.83 |
| Sep 30, 2021 | 0.52 |
| Jun 30, 2021 | 2.55 |
| Mar 31, 2021 | 33.88 |